No Data
No Data
Institutions Profited After Protara Therapeutics, Inc.'s (NASDAQ:TARA) Market Cap Rose US$60m Last Week but Individual Investors Profited the Most
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating
We Think Protara Therapeutics (NASDAQ:TARA) Needs To Drive Business Growth Carefully
H.C. Wainwright Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $23
Promising Efficacy of TARA-002 Positions Protara Therapeutics as a Compelling Buy for HR-NMIBC Treatment
No Data
Candy077 OP : I'm in this chatroom alone. How am I the only stupid one? There are people in ELAB, and not here. SMH